4G Clinical’s randomization and trial supply management (RTSM) technology will be used in conjunction with Clarkston’s consulting services to manage the design and execution of increasingly intricate clinical trials.
Dave Kelleher at 4G told us, “Ultimately, our shared focus of accelerating clinical research and improving the lives of patients is driving this partnership.”
But the companies say that there’s more to the partnership than just accelerating research. The industry is changing, according to 4G, and technologies and capabilities must evolve to support it.
Irene Birbeck of Clarkston told us, “The clinical supply chain is supposed to make sure that patients have their prescribed drug at the time that they need it – that’s the simplest version of it. But that can be very complex, you’re not just getting a drug you’re getting a kit, it has to be randomized, all of that has to be tracked.”
As clinical operations change and grow there is an increasing need for complex trial designing which can prove to be difficult in some cases. Clarkston referenced working with a complex biologic in a niche trial population and the need to ensure that every piece of the puzzle goes right – which is where the partnership with 4G comes in.
“The impact of this technology on clinical operations will extend beyond the technological landscape to drive transformational change in R&D, an area where Clarkston has recognized expertise to drive further improvements across the business as a whole,” said Birbeck.
Per the collaboration, the companies will co-author industry reports and white papers regarding the latest trends impacting the clinical trial industry.
